Data Deep Dive Webinar

Data Deep Dive:
The Latest Insights from STRIDE-PAD and SOUL

Late-breaking data from the STRIDE and SOUL studies show semaglutide improved symptoms, walking distance, and quality of life for patients with PAD, with SOUL also showing a reduction in adverse limb events. In this 1-hour webinar, the lead authors of both studies will join a panel of multidisciplinary endovascular experts to unpack the implications of these findings, discuss the evolving landscape of medical therapies for PAD, and share top-line takeaways for clinicians.

Moderator: Joshua Beckman, MD

Panelists: Ehrin Armstrong, MD; Marc P. Bonaca, MD, MPH; Daniella Kadian-Dodov, MD; Raghu Kolluri, MD, MS; Sean Lyden, MD; Darren McGuire, MD; Sahil Parikh, MD

• The Current State of Medical Therapies to Improve Limb Outcomes in PAD
  Joshua Beckman, MD
• STRIDE-PAD
  Marc P. Bonaca, MD, MPH
• Panel Discussion
• SOUL
  Darren McGuire, MD
• Panel Discussion